Bill Detail
H.R. 3493
Congress: 119
Title
Global Fairness in Drug Pricing Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Ro Khanna [D-CA-17]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Jun 9, 8:26 PM · synced 20d ago
Introduced
2025-05-19
Data source mode: congress-gov
Bill Engagement
Global Fairness in Drug Pricing Act
Sponsor
Rep. Ro Khanna [D-CA-17]D
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cosponsors
2D · 5R
Bipartisan
LDA engagement
1 org · 1 filing
Top: America's Health Insurance Plans, Inc.…
Introduced
2025-05-19
Lobbyists on the case
1 org · 12 lobbyists · 1 filing mention H.R. 3493 (Global Fairness in Drug Pricing Act) in LDA disclosures.
Top orgs filing
- America's Health Insurance Plans, Inc. (AHIP)1 filing · 12 lobs
Lobbyists on this bill
- Gary Beck2026 Q1
- Sean Dickson2026 Q1
- Sean Dugan2026 Q1
- Aron Griffin2026 Q1
- Sohini Gupta2026 Q1
- Mark Hamelburg2026 Q1
- Shane Hand2026 Q1
- Anthony Mitchell2026 Q1
+ 4 more